scholarly article | Q13442814 |
P356 | DOI | 10.1111/1756-185X.12782 |
P698 | PubMed publication ID | 26555862 |
P2093 | author name string | Yang Xin | |
Xuan Liang | |||
Cao Yongping | |||
Chen Ming | |||
Fan Weimin | |||
Gu Xiaoyuan | |||
Hao Yongqiang | |||
Lin Jianhao | |||
Sun Tiansheng | |||
Sun Tiezheng | |||
Yao Jianhua | |||
P2860 | cites work | A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project | Q35249579 |
Symptomatic slow-acting drugs for osteoarthritis: what are the facts? | Q36663201 | ||
Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy | Q36837279 | ||
Non-surgical treatment of osteoarthritis-related pain in the elderly | Q40504756 | ||
The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis | Q41648917 | ||
Intra‐articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial | Q57389638 | ||
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system | Q24647595 | ||
Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study | Q33962332 | ||
Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit | Q34098373 | ||
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis | Q34456671 | ||
Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? | Q34828779 | ||
P433 | issue | 3 | |
P921 | main subject | osteoarthritis | Q62736 |
P304 | page(s) | 271-278 | |
P577 | publication date | 2015-11-11 | |
P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
P1476 | title | The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study. | |
P478 | volume | 19 |
Q26740998 | A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis |
Q49922324 | Osteoarthritis year in review 2017: clinical. |
Q49949689 | Recent advances in hyaluronic acid based therapy for osteoarthritis |
Q46820735 | Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis |
Search more.